JP2013528622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528622A5 JP2013528622A5 JP2013513360A JP2013513360A JP2013528622A5 JP 2013528622 A5 JP2013528622 A5 JP 2013528622A5 JP 2013513360 A JP2013513360 A JP 2013513360A JP 2013513360 A JP2013513360 A JP 2013513360A JP 2013528622 A5 JP2013528622 A5 JP 2013528622A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cadherin
- optionally
- composition according
- der
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35150510P | 2010-06-04 | 2010-06-04 | |
| US61/351,505 | 2010-06-04 | ||
| PCT/US2011/039002 WO2011153397A2 (en) | 2010-06-04 | 2011-06-03 | Treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013528622A JP2013528622A (ja) | 2013-07-11 |
| JP2013528622A5 true JP2013528622A5 (enExample) | 2014-07-24 |
Family
ID=45067307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513360A Pending JP2013528622A (ja) | 2010-06-04 | 2011-06-03 | 炎症性障害の処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130209476A1 (enExample) |
| EP (1) | EP2575883B1 (enExample) |
| JP (1) | JP2013528622A (enExample) |
| AU (1) | AU2011261323A1 (enExample) |
| CA (1) | CA2805270C (enExample) |
| IL (1) | IL223385B (enExample) |
| WO (1) | WO2011153397A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130068691A1 (en) * | 2011-08-05 | 2013-03-21 | Henry John Smith | Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders |
| US11097005B2 (en) | 2014-12-15 | 2021-08-24 | The Brigham And Women's Hospital, Inc. | Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity |
| WO2018013957A1 (en) * | 2016-07-14 | 2018-01-18 | Greco Chad | Hybrid formulation of responsive polymeric nanocarriers for therapeutic and diagnostic delivery |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610281A (en) | 1994-05-03 | 1997-03-11 | Brigham & Women's Hospital, Inc. | Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes |
| US7481999B2 (en) * | 1998-05-05 | 2009-01-27 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin-mediated function |
| US6787136B1 (en) * | 1999-09-03 | 2004-09-07 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| ES2361541T3 (es) * | 2002-06-06 | 2011-06-17 | Oncotherapy Science, Inc. | Genes y polipéptidos relacionados con cánceres de colon humanos. |
| AU2004232362C1 (en) * | 2003-04-23 | 2008-05-29 | E. R. Squibb & Sons, L.L.C. | Compositions and methods for the therapy of inflammatory bowel disease |
| US20050002919A1 (en) * | 2003-06-09 | 2005-01-06 | The Brigham And Women's Hospital, Inc. | Cadherin directed molecular and cellular localization |
| MY162179A (en) * | 2004-04-01 | 2017-05-31 | Elan Pharm Inc | Steroid sparing agents and methods of using same |
| EP2156184B1 (en) * | 2007-05-08 | 2013-11-27 | Picobella, LLC | Methods for diagnosing and treating prostate and lung cancer |
| EP2245067A2 (en) * | 2008-02-11 | 2010-11-03 | Novartis AG | Methods of using cadherin 11 (cdh11) antagonists |
| WO2010091384A2 (en) * | 2009-02-09 | 2010-08-12 | Georgetown University | Cadherin-11 inhibitors and methods of use thereof |
| US8877188B2 (en) * | 2010-05-04 | 2014-11-04 | The Brigham And Women's Hospital, Inc. | Detection and treatment of non-dermal fibrosis |
| KR20190000385A (ko) * | 2010-05-04 | 2019-01-02 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 섬유증의 검출 및 치료 |
-
2011
- 2011-06-03 JP JP2013513360A patent/JP2013528622A/ja active Pending
- 2011-06-03 EP EP11790443.3A patent/EP2575883B1/en active Active
- 2011-06-03 US US13/702,018 patent/US20130209476A1/en not_active Abandoned
- 2011-06-03 WO PCT/US2011/039002 patent/WO2011153397A2/en not_active Ceased
- 2011-06-03 AU AU2011261323A patent/AU2011261323A1/en not_active Abandoned
- 2011-06-03 CA CA2805270A patent/CA2805270C/en active Active
-
2012
- 2012-12-02 IL IL223385A patent/IL223385B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fanelli et al. | Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-α1 | |
| van Koppen et al. | Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease | |
| Matsumoto et al. | CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model | |
| Yang et al. | Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats | |
| JP2014526441A5 (enExample) | ||
| Momcilović et al. | CXCL12 in control of neuroinflammation | |
| NZ599315A (en) | Antibody therapeutics with local activity in the digestive tract | |
| CN115227826A (zh) | Rxr激动剂和甲状腺激素在制备用于治疗自身免疫疾病的药物中的用途 | |
| US20230129866A1 (en) | Methods of treating respiratory disease with deupirfenidone | |
| Martinez et al. | Anesthesia for kidney transplantation—a review | |
| WO2021183774A1 (en) | Treating acute respiratory distress | |
| JP2013528622A5 (enExample) | ||
| Ai et al. | Paeonol ameliorates diabetic nephropathy by promoting TFEB-mediated lysosome biogenesis and lipophagy | |
| Garcia-Dorado et al. | Primary results of the PROMISE trial: myocardial protection with intracoronary adenosine given before reperfusion in patients with STEMI | |
| Govaert et al. | Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium | |
| CN106714842A (zh) | 包含双重PI3K δ‑γ激酶抑制剂和皮质类固醇的治疗方法及组合物 | |
| CN104777213A (zh) | 肌动蛋白结合蛋白2筛选平滑肌功能障碍疾病治疗药物的用途 | |
| WO2023001305A1 (zh) | 缓解或治疗纤维化性疾病的药物组合物或药盒及其应用 | |
| JP2018500882A5 (enExample) | ||
| CN104644620B (zh) | 化合物xl‑001在制备治疗慢性肾脏病的药物中的用途 | |
| Krenn et al. | Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial | |
| JP2014079188A (ja) | 無菌性慢性前立腺炎非ヒトモデル動物、頻尿非ヒトモデル動物およびこれらを用いた被験物質の評価方法 | |
| Church et al. | The artificial placenta rescues premature lambs from Ventilatory failure | |
| Suda et al. | Spherical sulfated cellulose adsorbs high-mobility-group box chromosomal protein 1 in vitro and in vivo | |
| Lieberman et al. | Preliminary Findings from the Phase 2 EPPIK Study of Sparsentan in Pediatric Patients with Selected Proteinuric Glomerular Diseases: SA-OR84 |